We are live on
!
Find out more
EMG
ETF Managers Group Portfolio holdings
AUM
$3.1B
Turnover
42.86%
1-Year Est. Return
17.12%
This Fund
S&P 500
This Quarter
Est. Return
+0.7%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$4.98B
AUM Growth
-$67M
(-1.3%)
Cap. Flow
+$45.9M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
23.75%
Holding
764
New
67
Increased
404
Reduced
223
Closed
63
Avg Time Held
2
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Okta
OKTA
|
+$72.3M |
| 2 |
VeriSign
VRSN
|
+$67.1M |
| 3 |
Zscaler
ZS
|
+$66.3M |
| 4 |
Cloudflare
NET
|
+$56.6M |
| 5 |
CrowdStrike
CRWD
|
+$54.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$46.3M |
| 2 |
N-able
NABL
|
+$40.2M |
| 3 |
SolarWinds Corporation Common Stock
SWI
|
+$37.9M |
| 4 |
PING
Ping Identity Holding Corp.
PING
|
+$32M |
| 5 |
Commault Systems
CVLT
|
+$31.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 49.28% |
| 2 | Materials | 17.18% |
| 3 | Healthcare | 8.92% |
| 4 | Financials | 6.61% |
| 5 | Industrials | 4.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
Blackbaud
BLKB
$2.22B
| $204K | ﹤0.01% |
3,386
-621
| -15% | -$40.5K |
2020 Q2
7 quarters
|
|
602
PagerDuty
PD
$1.31B
| $198K | ﹤0.01% |
5,602
-1,481
| -21% | -$47.6K |
2020 Q2
7 quarters
|
|
603
Victoria's Secret
VSXY
$7.05B
| $198K | ﹤0.01% |
3,751
+66
| +2% | +$3.59K |
2021 Q3
2 quarters
|
|
604
Synopsys
SNPS
$92B
| $192K | ﹤0.01% |
576
-3,470
| -86% | -$1.08M |
2021 Q4
1 quarter
|
|
605
DELISTED
Vaxart
VXRT
| $190K | ﹤0.01% |
38,162
+295
| +0.8% | +$1.49K |
2020 Q2
7 quarters
|
|
606
DELISTED
REE Automotive
REE
| $189K | ﹤0.01% |
3,240
-254
| -7% | -$25.9K |
2021 Q4
1 quarter
|
|
607
Atea Pharmaceuticals
AVIR
$371M
| $179K | ﹤0.01% |
25,245
+129
| +0.5% | +$876 |
2020 Q4
5 quarters
|
|
|
HZNP
608
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $176K | ﹤0.01% |
+1,668
| New | +$163K |
2022 Q1
0 quarters
|
|
609
Invivyd
IVVD
$179M
| $169K | ﹤0.01% |
33,746
+148
| +0.4% | +$905 |
2021 Q3
2 quarters
|
|
610
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
| $167K | ﹤0.01% |
37,841
-43
| -0.1% | -$237 |
2021 Q4
1 quarter
|
|
611
Morgan Stanley
MS
$285B
| $166K | ﹤0.01% |
+1,841
| New | +$178K |
2022 Q1
0 quarters
|
|
612
SIGA Technologies
SIGA
$223M
| $164K | ﹤0.01% |
22,482
+89
| +0.4% | +$595 |
2020 Q2
7 quarters
|
|
613
Spruce Power Holding Corp
SPRU
$28.3M
| $162K | ﹤0.01% |
9,674
+162
| +2% | +$2.82K |
2021 Q2
3 quarters
|
|
614
Rackspace Technology
RXT
$803M
| $157K | ﹤0.01% |
13,684
-3,832
| -22% | -$45.3K |
2020 Q3
6 quarters
|
|
615
Zeta Global
ZETA
$8.1B
| $155K | ﹤0.01% |
12,979
-3,186
| -20% | -$32.3K |
2021 Q3
2 quarters
|
|
616
OraSure Technologies
OSUR
$256M
| $153K | ﹤0.01% |
21,851
+79
| +0.4% | +$631 |
2020 Q2
7 quarters
|
|
617
AFC Gamma
AFCG
$66.5M
| $149K | ﹤0.01% |
11,374
-8,541
| -43% | -$115K |
2021 Q3
2 quarters
|
|
618
Fastly Inc
FSLY
$3.98B
| $140K | ﹤0.01% |
7,838
-2,021
| -20% | -$47.2K |
2020 Q2
7 quarters
|
|
619
Super Micro Computer
SMCI
$23.5B
| $133K | ﹤0.01% |
33,600
-9,280
| -22% | -$38.4K |
2020 Q3
6 quarters
|
|
|
RMO
620
DELISTED
Romeo Power, Inc.
RMO
| $132K | ﹤0.01% |
83,432
+1,397
| +2% | +$2.94K |
2021 Q2
3 quarters
|
|
621
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $130K | ﹤0.01% |
2,602
+9
| +0.3% | +$445 |
2020 Q2
7 quarters
|
|
622
Lunai Bioworks
LNAI
$4.05M
| $129K | ﹤0.01% |
200
+3
| +2% | +$1.6K |
2020 Q3
6 quarters
|
|
623
Arbutus Biopharma
ABUS
$830M
| $122K | ﹤0.01% |
41,031
+97
| +0.2% | +$297 |
2020 Q2
7 quarters
|
|
624
DELISTED
Chimerix, Inc.
CMRX
| $122K | ﹤0.01% |
26,398
+142
| +0.5% | +$791 |
2020 Q2
7 quarters
|
|
625
T1 Energy
TE
$869M
| $114K | ﹤0.01% |
9,947
+1,285
| +15% | +$12.3K |
2021 Q3
2 quarters
|
|
Similar funds
PFM
HT
JCG
QA
BFG
IMOV
ETF Managers Group's Q1 2022 Portfolio in Review
As of Q1 2022, ETF Managers Group held 764 positions worth $4.98B, down 1.3% from $5.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ETF Managers Group's Q1 2022 filing shows 67 new, 404 increased, 223 reduced and 63 closed positions. Its largest new stake was Bank of New York Mellon: 78,337 shares worth $4.06M. The largest sale was Arena Pharmaceuticals Inc, an estimated $46.3M.
By sector, the portfolio is most concentrated in Technology at 49% of assets, down from 50% a quarter earlier, followed by Materials and Healthcare.
- ETF Managers Group's largest Q1 2022 buy was Bank of New York Mellon: 78,337 shares worth $4.06M.
- ETF Managers Group added most to Okta in Q1 2022, an estimated $72.3M increase.
- ETF Managers Group's biggest Q1 2022 reduction was N-able, cutting an estimated $40.2M.
- ETF Managers Group fully exited Arena Pharmaceuticals Inc in Q1 2022, selling an estimated $46.3M.
- ETF Managers Group's ten largest holdings make up 24% of its $4.98B portfolio in Q1 2022.
- ETF Managers Group opened 67 new positions and closed 63 in Q1 2022.
- ETF Managers Group's portfolio value fell 1.3% quarter-over-quarter to $4.98B.
Based on ETF Managers Group's 13F filing for Q1 2022, filed 13 May 2022.